WREG

FDA allows pharmacists to automatically swap ‘generic’ insulin for brand-name

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. U.S. regulators took action Wednesday that ...
Miami Herald

Biocon Biologics And Civica Team To Launch Private-Label Insulin Glargine In The U.S.

In a move aimed at expanding affordable treatment options for millions of Americans living with diabetes, Biocon Biologics Ltd. and nonprofit generic drug manufacturer Civica, Inc. have announced a ...

How Drug Makers Manipulate Patents to Keep Insulin Prices High

Pharmaceutical companies layer on patents for drug delivery devices to maintain market exclusivity, according to a new study.
The Conversation

Despite what you learned at school, insulin isn’t just made in the pancreas

Craig Beall currently receives funding from Diabetes UK, Breakthrough T1D, Steve Morgan Foundation Type 1 Diabetes Grand Challenge, Medical Research Council, NC3Rs, Society for Endocrinology and ...